INVESTORS & MEDIA

Media Statements

Media Statements

Regeneron Statement on Novartis Withdrawing Anti-VEGF Pre-Filled Syringe Case in the International Trade Commission
EMA Commences Rolling Review of Regeneron’s COVID-19 Antibody Cocktail
Regeneron Statement on Preliminary Injunction of the Most Favored Nation Rule

IR Tools